# Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

> **NCT00120705** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 204 (—)

## Conditions studied

- Neoplasms
- Anemia

## Interventions

- **DRUG:** darbepoetin alfa

## Key facts

- **NCT ID:** NCT00120705
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 204 (—)
- **Last updated:** 2009-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120705, "Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00120705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*